Ultrafiltration membranes used in pharmaceutical manufacturing and other industrial processes have long relied on separating ...
MDNA113, Medicenna’s first-in-class tumor-anchored and masked anti-PD-1 x IL-2 bispecific program, is being evaluated in non-human primate studies, with plans for a first-in-human clinical trial to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback